Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction (Q44392643)

2 December 2017

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction (English)

1 reference

2 December 2017

0 references

ventricular dysfunction

1 reference

inferred from title

author

Jean-Pierre Marolleau

13

object named as

Jean-Pierre Marolleau

0 references

Patrick Bruneval

11

object named as

Patrick Bruneval

1 reference

2 December 2017

1

Philippe Menasché

1 reference

2 December 2017

Albert A Hagège

2

1 reference

2 December 2017

Jean-Thomas Vilquin

3

1 reference

2 December 2017

Michel Desnos

4

1 reference

2 December 2017

Eric Abergel

5

1 reference

2 December 2017

Bruno Pouzet

6

1 reference

2 December 2017

Alain Bel

7

1 reference

2 December 2017

Sorin Sarateanu

8

1 reference

2 December 2017

Marcio Scorsin

9

1 reference

2 December 2017

Ketty Schwartz

10

1 reference

2 December 2017

Marc Benbunan

12

1 reference

2 December 2017

Jean-Pierre Marolleau

13

1 reference

2 December 2017

Denis Duboc

14

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Journal of the American College of Cardiology

2 December 2017

1 reference

2 December 2017

41

1 reference

2 December 2017

1078-1083

1 reference

2 December 2017

7

1 reference

Economics of chronic heart failure.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Skeletal myoblast transplantation for repair of myocardial necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Cellular therapy reverses myocardial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Myoblast transplantation for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion. An experimental evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerte

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Factors affecting functional outcome after autologous skeletal myoblast transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Diversity of mammalian voltage-gated sodium channels.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

A dual-marker system for quantitative studies of myoblast transplantation in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Chimerism of the transplanted heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Preoperative Positron Emission Tomographic Viability Assessment and Perioperative and Postoperative Risk in Patients With Advanced Ischemic Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Reversibility of cardiac wall-motion abnormalities predicted by positron tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Positron emission tomography and low-dose dobutamine echocardiography in the prediction of postrevascularization improvement in left ventricular function and exercise parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900092-5

7 January 2021

10.1016/S0735-1097(03)00092-5

Identifiers

DOI

1 reference

2 December 2017

1 reference